Nicholas Saraceno

California Natural Color's showcase at this year's IFT event reflects a broader industry shift toward reformulating red-hued products, as synthetic dye alternatives face increasing regulatory pressure.

NPA's Daniel Fabricant, PhD, draws on his time as former director of FDA's Division of Dietary Supplement Programs to explain the agency's regulatory mindset, then lays out the association's near-term priorities.

The acquisition gives the natural ingredients group direct sourcing control at origin for a hydrocolloid increasingly used in appetite management and clean-label formulations.

In the fourth episode, Nicholas Saraceno unpacks why negative media coverage of omega-3 research doesn't always tell the full story, and what finished product manufacturers and consumers alike should understand about reading past a headline to the actual study design.

The rigid plastic packaging manufacturer's inaugural GRI-aligned report details emissions and waste reductions, offering finished product manufacturers a data point for evaluating packaging partners on sustainability performance rather than marketing claims alone.

NPA's president and CEO explains how the organization decides when to challenge industry-critical research, breaks down what he sees as “flawed” methodology in a recent glucosamine-Alzheimer's study, and weighs in on a lawsuit that could reshape how supplement health claims are made.

As spermidine research expands, an ingredient commercialized nearly 90 years ago is getting a second look from manufacturers seeking whole-food sources of the compound alongside protein and fiber.

Data on a fermentation-derived salidroside complex offers manufacturers a sustainably sourced alternative to Rhodiola rosea extract, a plant now facing supply pressure after its 2023 CITES listing.

As a new lawsuit challenges FDA's food-only interpretation of authoritative health claims, Steve Mister, president and CEO of CRN, discusses its own First Amendment case over New York's age restrictions and how Sergeant Searchlight fits into serious policy advocacy.

New ADM research spanning five countries shows pet owners are increasingly willing to pay for longevity-focused products, though what "longevity" means to them varies sharply by market.

The association’s president and CEO explains the strategy behind Sergeant Searchlight, and why voluntary product databases fall short of the mandatory registry the industry has pursued for 6 years.

The acquisition brings an established aromatherapy and essential oils brand into Country Life's portfolio, signaling continued consolidation among natural health and wellness companies.

A peer-reviewed pilot study on Exclzyme Pet reports improved mobility scores and lower inflammatory markers in arthritic dogs.

A new analysis of 5 randomized controlled trials finds a split picture: some evidence of benefit when creatine is added to standard treatment, and 3 trials that found no effect.

Nutritional Outlook interviews Andrew Ross, DO, Rousselot's science liaison and writer, who makes the case that blending collagen peptides into existing formulas isn't just a cost play, it's a functional and nutritional upgrade.

UNPA, one of the architects of the Dietary Supplement Health and Education Act, will wind down operations at the end of 2026, prompting reflection across the industry on the regulatory framework it helped build.

A randomized controlled trial reports that a low-dose saffron extract improved mood, sleep-related impairment, and self-esteem scores in women aged 50 to 70, adding a multidimensional angle to a body of research that has focused largely on depressive symptoms alone.

Vitamin K2 has become a staple cofactor in bone and cardiovascular health formulations, but the differences between its 2 major commercial forms, MK-4 and MK-7, carry real implications for dosing, claims, and sourcing.

A new crossover trial finds that a whole-food Chardonnay grape matrix outperformed a concentrated seed extract on one marker of cardiometabolic health.

With GLP-1 medications creating an entirely new supplement category almost overnight, a look at the science, the claims, and where the evidence actually stands.

In the third episode, Nicholas Saraceno discusses why male hair thinning is increasingly being understood as a multifactorial, systemic health issue rather than a purely cosmetic one, and what that shift means for how the supplement industry formulates and substantiates products for men.

Maypro's new distribution partnership with Asahi Group Foods brings a clinically studied milk peptide to North American formulators targeting the cognitive health category.

Harry Rice breaks down GOED's comments to FDA on safety-based ingredient standards, and explains what recent headline-grabbing studies on omega-3s and cognitive health actually do and don't tell us.

A 2024 UK regulatory determination on the novel food status of monk fruit decoctions has added momentum to a less-refined ingredient format that formulators are positioning as a clean-label alternative to high-purity mogroside extracts.

From El Niño disruptions to the Peruvian anchovy fishery to a forthcoming expert panel recommendation on EPA and DHA, GOED's Harry Rice breaks down what's shaping the omega-3 category in 2026.

The dual regulatory clearance gives formulators authorized claims language in two jurisdictions for an ingredient already supported by published randomized controlled trial data on sleep quality and cortisol reduction.

The regulatory distinction extends an already-established human health probiotic strain into the companion animal category, adding to a growing list of pet supplement ingredients seeking formal recognition in Canada's veterinary health product framework.

A new collaboration with genomics company LeafWorks gives the supplement manufacturer in-house sequencing capability paired with a commercial analysis platform.

Brevel-Coffeesai collaboration highlights how light-enabled bioprocessing could help ingredient developers address scale, consistency, and supply challenges in coffee-derived products.

The market intelligence certification highlights continued growth in lichen-derived vitamin D3, as formulators seek alternatives to the lanolin-based sourcing that has long dominated the category.